Drugs / SP-304
last change Aug 2010 re-read 3 minutes ago

SP-304

Developed for
constipation disorder
Investigated by
Bausch Health Americas, Inc.

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01053962 Mar → Aug 2010 constipation disorder Bausch Health Americas, Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SP-304 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01053962 ↗
Route Oral “by mouth” NCT01053962 ↗